FIFTH CIRCUIT COURT OF APPEALS
-
Biotech giant Illumina will unwind takeover of cancer-screening company Grail
San Diego-based Illumina said in a Sunday statement that it made its decision to divest Grail after a U.S. appeals court ruled Friday that the merger could violate antitrust laws.
Advertisement
Advertisement